Breast Cancer Profiling Project, Drug Sensitivity phase II: Fixed-cell GR measures of 33 breast cell lines and PDX lines to 16 small molecule perturbagens from library plate II. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20354)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Mean Normalized Growth Rate Inhibition Value | Increased Fraction Dead |
|---|---|---|---|---|
| MCF 10A | Alvocidib | 0.316227766017 | -0.4123 | 0.79577 |
| MCF 10A | Alvocidib | 0.316227766017 | -0.3048 | 0.69157 |
| HCC1395 | Alvocidib | 0.000316227766017 | 0.7796 | 0.00635 |
| MDA-MB-134-VI | Alvocidib | 0.000316227766017 | 0.9489 | -0.02391 |
| SK-BR-3 | Alvocidib | 0.0001 | 1.1503 | -0.00206 |
| SK-BR-3 | Alvocidib | 0.0001 | 0.9030 | -0.00889 |
| HCC1395 | Alvocidib | 0.000316227766017 | 0.8649 | 0.00977 |
| MDA-MB-134-VI | Alvocidib | 0.0001 | 0.8267 | -0.02010 |
| MDA-MB-134-VI | Alvocidib | 0.0001 | 0.8039 | -0.02698 |
| MDA-MB-134-VI | Alvocidib | 0.0001 | 1.3544 | -0.03047 |
| HCC1395 | Alvocidib | 0.01 | 0.9916 | 0.02137 |
| HCC1143 | Alvocidib | 0.01 | 0.9857 | 0.00348 |
| HCC1395 | Alvocidib | 0.1 | 0.6860 | 0.01323 |
| HCC1395 | Alvocidib | 0.316227766017 | 0.0265 | 0.01840 |
| HCC1143 | Alvocidib | 1.0 | -0.3370 | 0.25392 |
| HCC1143 | Alvocidib | 0.1 | 0.7392 | 0.01572 |
| HCC1419 | Alvocidib | 0.01 | 0.9485 | 0.01266 |
| HCC1395 | Alvocidib | 0.00316227766017 | 0.8244 | -0.00540 |
| HCC1143 | Alvocidib | 0.01 | 0.9239 | -0.00059 |
| HCC1395 | Alvocidib | 0.0316227766017 | 0.7201 | -0.00765 |
| HCC1395 | Alvocidib | 0.01 | 0.7707 | -0.00317 |
| HCC1395 | Alvocidib | 0.01 | 0.6461 | 0.04223 |
| HCC1143 | Alvocidib | 0.00316227766017 | 0.9381 | 0.00361 |
| SK-BR-3 | Alvocidib | 0.00316227766017 | 0.6052 | -0.00398 |
| SK-BR-3 | Alvocidib | 0.00316227766017 | 0.8916 | -0.00394 |